Literature DB >> 15187005

The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.

Mahmoud Loghman-Adham1, Carlos E Soto, Tadashi Inagami, Lisa Cassis.   

Abstract

Hypertension is a common complication of autosomal dominant polycystic kidney disease (ADPKD), often present before the onset of renal failure. A role for the renin-angiotensin system (RAS) has been proposed, but studies of systemic RAS have failed to show a correlation between plasma renin activity and blood pressure in ADPKD. Ectopic renin expression by cyst epithelium was first reported in 1992 (Torres VE, Donovan KA, Sicli G, Holley KE, Thibodeau ST, Carretero OA, Inagami T, McAteer JA, and Johnson CM. Kidney Int 42: 364-373, 1992). It is not known, however, whether other RAS components are also expressed by cysts in ADPKD. We show that, in addition to renin, angiotensinogen (AGT) is produced by some cysts and dilated tubules. Angiotensin-converting enzyme, ANG II type 1 receptor, and ANG II peptide are also present within cysts and in many tubules; and some cyst fluids contain high ANG II concentrations. Additionally, cyst-derived cells in culture continue to express the components of the RAS at both the protein and mRNA levels. We further show that renin is expressed primarily in cysts of distal tubule origin and in cyst-derived cells with distal tubule characteristics, whereas AGT is expressed primarily in cysts of proximal tubule origin and in cyst-derived cells with proximal tubule characteristics. Renin production by cyst-derived cells appears to be regulated by extracellular Na+ concentration. Based on these observations, we propose a model of an autocrine/paracrine RAS in polycystic kidney disease, whereby overactivity of the intrarenal system results in sustained increases in intratubular ANG II concentrations.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15187005     DOI: 10.1152/ajprenal.00370.2003

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  47 in total

1.  Angiotensin blockade in late autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Kaleab Z Abebe; Arlene B Chapman; Robert W Schrier; William E Braun; Theodore I Steinman; Franz T Winklhofer; Godela Brosnahan; Peter G Czarnecki; Marie C Hogan; Dana C Miskulin; Frederic F Rahbari-Oskoui; Jared J Grantham; Peter C Harris; Michael F Flessner; Charity G Moore; Ronald D Perrone
Journal:  N Engl J Med       Date:  2014-11-15       Impact factor: 91.245

Review 2.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 3.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

4.  Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark.

Authors:  Bjarne Orskov; Vibeke Rømming Sørensen; Bo Feldt-Rasmussen; Svend Strandgaard
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-29       Impact factor: 8.237

5.  Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.

Authors:  Takamitsu Saigusa; Yujing Dang; Adam E Mullick; Steve T Yeh; Michael R Zile; Catalin F Baicu; P Darwin Bell
Journal:  FASEB J       Date:  2015-09-21       Impact factor: 5.191

6.  Similar renal outcomes in children with ADPKD diagnosed by screening or presenting with symptoms.

Authors:  Djalila Mekahli; Adrian S Woolf; Detlef Bockenhauer
Journal:  Pediatr Nephrol       Date:  2010-08-05       Impact factor: 3.714

Review 7.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

8.  Identification of cis-regulatory sequences in the human angiotensinogen gene by transgene coplacement and site-specific recombination.

Authors:  Taku Shimizu; Takayuki Oishi; Akane Omori; Akiko Sugiura; Keiko Hirota; Hisanori Aoyama; Tomoko Saito; Takeshi Sugaya; Yasuhiro Kon; James Douglas Engel; Akiyoshi Fukamizu; Keiji Tanimoto
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

9.  Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

Authors:  Imed Helal; Kim McFann; Berenice Reed; Xiang-Dong Yan; Robert W Schrier; Godela M Fick-Brosnahan
Journal:  Nephrol Dial Transplant       Date:  2012-12-04       Impact factor: 5.992

Review 10.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.